Large-scale testing (Phase 3)WithdrawnNCT04244877
What this trial is testing
Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility
Who this might be right for
Cirrhosis, LiverMinimal Hepatic EncephalopathySmall Intestinal Bacterial Overgrowth+1 more
MetroHealth Medical Center